Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Lymphoma, T-Cell × Flavin-Adenine Dinucleotide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell 1

Interventions

Cyclophosphamide 13 fludarabine 9 Brentuximab Vedotin 9 fludarabine phosphate 7 Whole-Body Irradiation 7 Gemcitabine 7 Mycophenolic Acid 6 Busulfan 6 Melphalan 5 Granulocyte Colony-Stimulating Factor 5 Etoposide 5 Doxorubicin 5 pembrolizumab 4 Vorinostat 4 Vincristine 4 Stem Cell Transplantation 4 Rituximab 4 Prednisone 4 Peripheral Blood Stem Cell Transplantation 4 Filgrastim 4 romidepsin 3 etoposide phosphate 3 Tacrolimus 3 Sirolimus 3 Lenalidomide 3 Bortezomib 3 Biopsy 3 Bendamustine Hydrochloride 3 endostar protein 2 duvelisib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00840385 2010-09-15

FAD

Fudan University

Phase 2 Unknown

Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon ⚡